TrialMedical oncology (Northwood, London, England)2021

Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma.

Sahar K Hegazy et al.PubMed ↗Publisher ↗

No numbers read from the abstract.